tirzepatide and hyperthyroidism thyroid nodules: what the research actually shows about safety Tirzepatide and Cancer Risk in

PMID: 30561426

Tirzepatide works through a dual-action mechanism by targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors

Honorable Mention: Mounjaro (tirzepatide) Indication(s): Type 2 diabetes, chronic weight management Manufacturer(s): Eli Lilly 2024 Sales (USD): $11.54 billion 2025 Outlook: While Mounjaro itself is not approved for weight loss, it drove significant off-label use before Zepbounds launch and helped set the stage for the obesity-focused branding strategy that now powers Lillys market dominance

PNPLA3 I148M mediates the regulatory effect of NFkB on inflammation in PAtreated HepG2 cells